ClinicalTrials.Veeva

Menu

Monitoring Obese Patients : Impact on the Frequency of Monitoring Weight (SUIVIOBESITE)

U

University of Limoges (UL)

Status

Completed

Conditions

Quality of Life
Obesity
Morbid Obesity

Treatments

Other: closer monitoring

Study type

Interventional

Funder types

Other

Identifiers

NCT02374866
I13031 SUIVI OBESITE

Details and patient eligibility

About

The literature data show that long-term monitoring has an effect on weight loss, comorbidity and on improving the quality of life. However, there are still no studies on monitoring obese patients after taking initial multidisciplinary approach. The recommendations of the HAS 2011 advocated "continuous monitoring needed to prevent weight regain, monitor the consequences of overweight and treat comorbidities. This requires a long-term support. "The frequency of follow-up consultations is not specified and "must be adapted to achieve a weight loss target and maintain." Having no specific recommendations on the frequency of monitoring, the investigators chose to experiment closer monitoring than our current monitoring to assess what is the best frequency monitoring, in terms of: weight loss, quality of life, feeding behavior, changes in physical abilities, evolution of comorbidities associated with obesity. The recommendations of the HAS 2011 advocate support of a multidisciplinary obesity for weight loss of 5% to 10 %, which, if maintained, can reduce comorbidities associated with obesity (type 2 diabetes, hypertension, pain associated with osteoarthritis).

Full description

2 groups of randomized patients will be followed:

  • The control group will follow the current center: every four months for a year, combined with monitoring by email or regular mail during the year.
  • The experimental group will be a follow-up every two months for one year HDJ more of the same followed by email or postal mail.

Follow by email or mail is identical to the control group, as well as HDJ 12 months.

Enrollment

96 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    • Age ≥ 18 - ≤ 75 years
  • Obesity with a BMI ≥ 35 or ≥ 30 if associated with at least one comorbidity whose support was commenced or continued during the initial hospitalization.
  • Patients hospitalized for a period of at least 3 weeks in the Bernard Descottes center and were supported on dietary, psychological, psychomotor and physical education in a therapeutic approach.
  • Patients who have signed consent form.
  • Patients who never underwent bariatric surgery and bariatric surgery have not seen in the year following their hospitalization in Bernard Descottes Center.
  • Patient accepting the constraints of the protocol in case of close monitoring.
  • Patients able to travel with their own vehicle to Bernard Descottes Center.
  • Affiliate or beneficiary of a social security scheme

Exclusion criteria

    • Patients who have hospitalized in Bernard Descottes Center.
  • Failure to follow the protocol because of insufficient command of French or concomitant illness.
  • Pregnant or breastfeeding.
  • Patients under guardianship or under judicial protection.
  • Participation to another trial which can impact on patient's experimental disease during all the study, and patients who are in an exclusion period of another trial.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

96 participants in 2 patient groups

Conventional monitoring
No Intervention group
Description:
The control group will follow the current center: every four months for a year, combined with monitoring by email or regular mail during the year.
Closer monitoring
Experimental group
Description:
The experimental group will follow a closer monitoring than the control group : every two months for one year in,stead of every 4 months for a year. Follow by email or mail is identical to the control group.
Treatment:
Other: closer monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems